BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 15220403)

  • 81. Activation of the Kaposi's sarcoma-associated herpesvirus major latency locus by the lytic switch protein RTA (ORF50).
    Matsumura S; Fujita Y; Gomez E; Tanese N; Wilson AC
    J Virol; 2005 Jul; 79(13):8493-505. PubMed ID: 15956592
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
    Chang PJ; Chen LW; Chen LY; Hung CH; Shih YJ; Wang SS
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701396
    [TBL] [Abstract][Full Text] [Related]  

  • 83. X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency.
    Wilson SJ; Tsao EH; Webb BL; Ye H; Dalton-Griffin L; Tsantoulas C; Gale CV; Du MQ; Whitehouse A; Kellam P
    J Virol; 2007 Dec; 81(24):13578-86. PubMed ID: 17928342
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A naturally occurring C-terminal truncated isoform of the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus does not associate with viral episomal DNA.
    Canham M; Talbot SJ
    J Gen Virol; 2004 Jun; 85(Pt 6):1363-1369. PubMed ID: 15166417
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Bub1 and CENP-F can contribute to Kaposi's sarcoma-associated herpesvirus genome persistence by targeting LANA to kinetochores.
    Xiao B; Verma SC; Cai Q; Kaul R; Lu J; Saha A; Robertson ES
    J Virol; 2010 Oct; 84(19):9718-32. PubMed ID: 20660191
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Kaposi's Sarcoma-associated herpesvirus lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway.
    Carroll KD; Bu W; Palmeri D; Spadavecchia S; Lynch SJ; Marras SA; Tyagi S; Lukac DM
    J Virol; 2006 Oct; 80(19):9697-709. PubMed ID: 16973574
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Role of the cellular transcription factor YY1 in the latent-lytic switch of Kaposi's sarcoma-associated herpesvirus.
    Chang PJ; Chen LW; Shih YC; Tsai PH; Liu AC; Hung CH; Liou JY; Wang SS
    Virology; 2011 May; 413(2):194-204. PubMed ID: 21376359
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) binds to, and inhibits transactivation of, CREB-binding protein.
    Seo T; Lee D; Lee B; Chung JH; Choe J
    Biochem Biophys Res Commun; 2000 Apr; 270(1):23-7. PubMed ID: 10733899
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promoters.
    Groves AK; Cotter MA; Subramanian C; Robertson ES
    J Virol; 2001 Oct; 75(19):9446-57. PubMed ID: 11533207
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Kaposi's Sarcoma-Associated Herpesvirus Hijacks RNA Polymerase II To Create a Viral Transcriptional Factory.
    Chen CP; Lyu Y; Chuang F; Nakano K; Izumiya C; Jin D; Campbell M; Izumiya Y
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331082
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen regulates the KSHV epigenome by association with the histone demethylase KDM3A.
    Kim KY; Huerta SB; Izumiya C; Wang DH; Martinez A; Shevchenko B; Kung HJ; Campbell M; Izumiya Y
    J Virol; 2013 Jun; 87(12):6782-93. PubMed ID: 23576503
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Inhibition of replication and transcription activator and latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus by morpholino oligomers.
    Zhang YJ; Wang KY; Stein DA; Patel D; Watkins R; Moulton HM; Iversen PL; Matson DO
    Antiviral Res; 2007 Jan; 73(1):12-23. PubMed ID: 16842866
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Analysis of Kaposi's sarcoma-associated herpesvirus latent replication using a real-time polymerase chain reaction technique.
    Cha S; Jang JH; Kim Y; Hwang LR; Seo T
    J Virol Methods; 2013 Nov; 193(2):660-6. PubMed ID: 23933394
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen and angiogenin interact with common host proteins, including annexin A2, which is essential for survival of latently infected cells.
    Paudel N; Sadagopan S; Balasubramanian S; Chandran B
    J Virol; 2012 Feb; 86(3):1589-607. PubMed ID: 22130534
    [TBL] [Abstract][Full Text] [Related]  

  • 95. KSHV genome harbors both constitutive and lytically induced enhancers.
    Roy Chowdhury N; Gurevich V; Shamay M
    J Virol; 2024 Jun; 98(6):e0017924. PubMed ID: 38695538
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The minimal replicator element of the Kaposi's sarcoma-associated herpesvirus terminal repeat supports replication in a semiconservative and cell-cycle-dependent manner.
    Verma SC; Choudhuri T; Robertson ES
    J Virol; 2007 Apr; 81(7):3402-13. PubMed ID: 17151118
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells.
    Hyun TS; Subramanian C; Cotter MA; Thomas RA; Robertson ES
    J Virol; 2001 Sep; 75(18):8761-71. PubMed ID: 11507221
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The ubiquitin-specific protease USP7 modulates the replication of Kaposi's sarcoma-associated herpesvirus latent episomal DNA.
    Jäger W; Santag S; Weidner-Glunde M; Gellermann E; Kati S; Pietrek M; Viejo-Borbolla A; Schulz TF
    J Virol; 2012 Jun; 86(12):6745-57. PubMed ID: 22514345
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1.
    Viejo-Borbolla A; Ottinger M; Brüning E; Bürger A; König R; Kati E; Sheldon JA; Schulz TF
    J Virol; 2005 Nov; 79(21):13618-29. PubMed ID: 16227282
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Characterization of the minimal replicator of Kaposi's sarcoma-associated herpesvirus latent origin.
    Hu J; Renne R
    J Virol; 2005 Feb; 79(4):2637-42. PubMed ID: 15681465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.